𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Systematic review: the use of mesalazine in inflammatory bowel disease

✍ Scribed by R. BERGMAN; M. PARKES

Book ID
108604487
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
240 KB
Volume
23
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Thromboembolism in pediatric inflammator
Thromboembolism in pediatric inflammatory bowel disease: Systematic review
✍ Marzia Lazzerini; Matteo Bramuzzo; Massimo Maschio; Stefano Martelossi; Alessand πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 191 KB πŸ‘ 1 views

Background: Several studies suggest an increased risk of venous and arterial thromboembolism (TE) in adults with inflammatory bowel disease (IBD) compared to the general population. We performed a systematic review of studies on incidence and characteristic of TE in children with IBD. Methods: We s

5-Aminosalicylates and renal function in
5-Aminosalicylates and renal function in inflammatory bowel disease: A systematic review
✍ Javier P. Gisbert; Yago GonzΓ‘lez-Lama; JosΓ© MatΓ© πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 114 KB πŸ‘ 2 views

Nephrotoxicity has been described in some patients with inflammatory bowel disease (IBD) treated with 5-aminosalicylic acid (5-ASA). Studies with 5-ASA treatment in which serum creatinine or creatinine clearance was measured regularly show that nephrotoxicity is exceptional (mean rate of only 0.26%

Epidemiology of pediatric inflammatory b
Epidemiology of pediatric inflammatory bowel disease: A systematic review of international trends
✍ Eric I. Benchimol; Kyle J. Fortinsky; Peter Gozdyra; Meta Van den Heuvel; Johan πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 418 KB πŸ‘ 1 views

Background: Temporal trends in the incidence of pediatriconset inflammatory bowel disease (IBD) are controversial and a wide range of estimates have been reported worldwide. We conducted a systematic review of research describing the epidemiology of childhood-onset IBD to assess changes in incidence